|
|
Volumn 1, Issue 12, 2002, Pages 937-938
|
|
The animal health market. Market indicators
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVANTAGE;
ANTINEOPLASTIC AGENT;
ANTIOBESITY AGENT;
ANTIPARASITIC AGENT;
CARDIOVASCULAR AGENT;
CARPROFEN;
FIPRONIL;
FRONTLINE;
HEARTGARD;
HORMONE DERIVATIVE;
IMIDACLOPRID;
INTERCEPTOR;
IVERMECTIN;
MILBEMYCIN DERIVATIVE;
NONSTEROID ANTIINFLAMMATORY AGENT;
VETERINARY DRUG;
ANIMAL CARE;
ANIMAL HEALTH;
ANIMAL PARASITOSIS;
ARTHRITIS;
BOVINE SPONGIFORM ENCEPHALOPATHY;
CLINICAL RESEARCH;
CONGESTIVE HEART FAILURE;
CROP PROTECTION;
DOG DISEASE;
DOMESTIC ANIMAL;
ENDOCRINE DISEASE;
FINANCIAL MANAGEMENT;
FOOD INDUSTRY;
FOOD SAFETY;
LIVESTOCK;
MALIGNANT NEOPLASTIC DISEASE;
MEAT;
NONHUMAN;
NOTE;
OBESITY;
POULTRY;
PRIORITY JOURNAL;
PRODUCTIVITY;
RESOURCE MANAGEMENT;
UNITED KINGDOM;
VETERINARY MEDICINE;
ANIMAL;
ARTICLE;
DRUG APPROVAL;
ECONOMIC ASPECT;
ECONOMICS;
HEALTH CARE COST;
POLICY;
UNITED STATES;
ANIMALS;
DRUG APPROVAL;
ECONOMIC COMPETITION;
GREAT BRITAIN;
HEALTH CARE SECTOR;
ORGANIZATIONAL POLICY;
UNITED STATES;
VETERINARY DRUGS;
VETERINARY MEDICINE;
|
|
EID: 0036885037
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd975 Document Type: Note |
|
Times cited : (18)
|
|
References (3)
|
